{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:56:49Z","timestamp":1787500609099,"version":"build-2736575974"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["971522"],"award-info":[{"award-number":["971522"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Health Agency Canada","award":["00"],"award-info":[{"award-number":["00"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007564","type":"journal-article","created":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T13:30:02Z","timestamp":1551360602000},"page":"e1007564","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Complete protection of the BALB\/c and C57BL\/6J mice against Ebola and Marburg virus lethal challenges by pan-filovirus T-cell epigraph vaccine"],"prefix":"10.1371","volume":"15","author":[{"given":"Md Niaz","family":"Rahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund G.","family":"Wee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-7489","authenticated-orcid":true,"given":"Jonathan","family":"Audet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Tierney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathifa","family":"Moyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-8476","authenticated-orcid":true,"given":"Zara","family":"Hannoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9724-8309","authenticated-orcid":true,"given":"Alison","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Baines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bette","family":"Korber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5578-9999","authenticated-orcid":true,"given":"Xiangguo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6076-9546","authenticated-orcid":true,"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,2,28]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nri1154","article-title":"Ebola virus: from discovery to vaccine","volume":"3","author":"H Feldmann","year":"2003","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.tim.2007.08.001","article-title":"The ecology of Ebola virus","volume":"15","author":"A Groseth","year":"2007","journal-title":"Trends Microbiol"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"SM Jones","year":"2005","journal-title":"Nat Med"},{"issue":"6249","key":"ref4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.aab3920","article-title":"EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014\/15 Ebola virus outbreak strain","volume":"349","author":"A Marzi","year":"2015","journal-title":"Science"},{"issue":"17","key":"ref5","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMoa1411627","article-title":"A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA","volume":"374","author":"K Ewer","year":"2016","journal-title":"N Engl J Med"},{"issue":"9996","key":"ref6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0140-6736(15)61117-5","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial","volume":"386","author":"AM Henao-Restrepo","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1086\/650299","article-title":"A phase 1\/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172)","volume":"201","author":"H Kibuuka","year":"2010","journal-title":"J Infect Dis"},{"key":"ref8","article-title":"Chimpanzee Adenovirus Vector Ebola Vaccine\u2014Preliminary Report","author":"JE Ledgerwood","year":"2014","journal-title":"N Engl J Med"},{"key":"ref9","article-title":"A Recombinant Vesicular Stomatitis Virus Ebola Vaccine\u2014Preliminary Report","author":"JA Regules","year":"2015","journal-title":"N Engl J Med"},{"issue":"9984","key":"ref10","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/S0140-6736(15)60553-0","article-title":"Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial","volume":"385","author":"FC Zhu","year":"2015","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"33987","DOI":"10.1038\/srep33987","article-title":"Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine","volume":"6","author":"J Theiler","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"e1000904","DOI":"10.1371\/journal.ppat.1000904","article-title":"Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species","volume":"6","author":"LE Hensley","year":"2010","journal-title":"PLoS Pathog"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"e0192312","DOI":"10.1371\/journal.pone.0192312","article-title":"A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates","volume":"13","author":"B Callendret","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"W Fischer","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/mt.2016.3","article-title":"Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection","volume":"24","author":"B Ondondo","year":"2016","journal-title":"Mol Ther"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/mt.2013.248","article-title":"Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1","volume":"22","author":"N Borthwick","year":"2014","journal-title":"Mol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/mtm.2016.61","article-title":"Broad HIV-1 inhibition in vitro by vaccine-elicited CD8+ T cells in African adults","volume":"3","author":"G Mutua","year":"2016","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"M Bray","year":"1998","journal-title":"J Infect Dis"},{"issue":"21","key":"ref19","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.1128\/JVI.01643-14","article-title":"Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus","volume":"88","author":"X Qiu","year":"2014","journal-title":"J Virol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/iid3.52","article-title":"Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques","volume":"3","author":"NJ Borthwick","year":"2015","journal-title":"Immun Inflamm Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/vir.0.19701-0","article-title":"An HIV-1 clade A vaccine in clinical trials: Stimulation of HIV-specific T cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans","volume":"85","author":"M Mwau","year":"2004","journal-title":"J Gen Virol"},{"issue":"11","key":"ref22","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.vaccine.2006.11.016","article-title":"Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: effects of dosage and route on safety and immunogenicity","volume":"25","author":"BS Peters","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.78.2.958-967.2004","article-title":"Persistent infection with ebola virus under conditions of partial immunity","volume":"78","author":"M Gupta","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"KL Warfield","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1128\/JVI.75.6.2660-2664.2001","article-title":"Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein","volume":"75","author":"JA Wilson","year":"2001","journal-title":"J Virol"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"DA Stanley","year":"2014","journal-title":"Nat Med"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nm.2447","article-title":"CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates","volume":"17","author":"NJ Sullivan","year":"2011","journal-title":"Nat Med"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T16:23:49Z","timestamp":1588955029000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007564"}},"subtitle":[],"editor":[{"given":"Jens H.","family":"Kuhn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,2,28]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007564","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,28]]}}}